477 related articles for article (PubMed ID: 27704320)
1. Association between serum γ-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study.
Shen ZW; Xing J; Wang QL; Faheem A; Ji X; Li J; Bian WW; Jiang Z; Li XJ; Xue FZ; Liu J
Int Urol Nephrol; 2017 Feb; 49(2):303-312. PubMed ID: 27704320
[TBL] [Abstract][Full Text] [Related]
2. Association between serum gamma-glutamyltransferase and chronic kidney disease among US adults.
Teppala S; Shankar A; Li J; Wong TY; Ducatman A
Kidney Blood Press Res; 2010; 33(1):1-6. PubMed ID: 20090360
[TBL] [Abstract][Full Text] [Related]
3. Gamma-glutamyltransferase and risk of chronic kidney disease: A prospective cohort study.
Kunutsor SK; Laukkanen JA
Clin Chim Acta; 2017 Oct; 473():39-44. PubMed ID: 28811239
[TBL] [Abstract][Full Text] [Related]
4. The relationship between gamma-glutamyl transferase levels and chronic kidney disease among Appalachian adults.
Cain LR; Ducatman AM; Shankar A
W V Med J; 2012; 108(1):8-13. PubMed ID: 25134186
[TBL] [Abstract][Full Text] [Related]
5. Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study.
Ochiai H; Shirasawa T; Yoshimoto T; Nagahama S; Watanabe A; Sakamoto K; Kokaze A
BMC Nephrol; 2020 Nov; 21(1):471. PubMed ID: 33172399
[TBL] [Abstract][Full Text] [Related]
6. Serum liver enzymes are associated with all-cause mortality in an elderly population.
Koehler EM; Sanna D; Hansen BE; van Rooij FJ; Heeringa J; Hofman A; Tiemeier H; Stricker BH; Schouten JN; Janssen HL
Liver Int; 2014 Feb; 34(2):296-304. PubMed ID: 24219360
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
Ruhl CE; Everhart JE
Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
[TBL] [Abstract][Full Text] [Related]
8. Gamma-glutamyltransferase and risk of prostate cancer: Findings from the KIHD prospective cohort study.
Kunutsor SK; Laukkanen JA
Int J Cancer; 2017 Feb; 140(4):818-824. PubMed ID: 27861848
[TBL] [Abstract][Full Text] [Related]
9. Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors.
Kim DJ; Noh JH; Cho NH; Lee BW; Choi YH; Jung JH; Min YK; Lee MS; Lee MK; Kim KW
Diabet Med; 2005 Sep; 22(9):1134-40. PubMed ID: 16108838
[TBL] [Abstract][Full Text] [Related]
10. Liver enzymes and incident diabetes in China: a prospective analysis of 10 764 participants in the Guangzhou Biobank Cohort Study.
Xu L; Jiang CQ; Schooling CM; Zhang WS; Cheng KK; Lam TH
J Epidemiol Community Health; 2015 Nov; 69(11):1040-4. PubMed ID: 26139641
[TBL] [Abstract][Full Text] [Related]
11. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men.
Ryu S; Chang Y; Kim DI; Kim WS; Suh BS
Clin Chem; 2007 Jan; 53(1):71-7. PubMed ID: 17110470
[TBL] [Abstract][Full Text] [Related]
12. The association between elevated serum uric acid level and an increased risk of renal function decline in a health checkup cohort in China.
Cao X; Wu L; Chen Z
Int Urol Nephrol; 2018 Mar; 50(3):517-525. PubMed ID: 29094330
[TBL] [Abstract][Full Text] [Related]
13. High levels of both serum gamma-glutamyl transferase and alkaline phosphatase are independent preictors of mortality in patients with stage 4-5 chronic kidney disease.
Caravaca-Fontán F; Azevedo L; Bayo MÁ; Gonzales-Candia B; Luna E; Caravaca F
Nefrologia; 2017; 37(3):267-275. PubMed ID: 28648203
[TBL] [Abstract][Full Text] [Related]
14. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British Health Surveys.
Kengne AP; Czernichow S; Stamatakis E; Hamer M; Batty GD
J Hepatol; 2012 Nov; 57(5):1083-9. PubMed ID: 22796154
[TBL] [Abstract][Full Text] [Related]
15. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Kim CH; Park JY; Lee KU; Kim JH; Kim HK
Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
[TBL] [Abstract][Full Text] [Related]
16. Baseline liver function tests and full blood count indices and their association with progression of chronic kidney disease and renal outcomes in Aboriginal and Torres Strait Islander people: the eGFR follow- up study.
Majoni SW; Barzi F; Hoy W; MacIsaac RJ; Cass A; Maple-Brown L; Hughes JT
BMC Nephrol; 2020 Dec; 21(1):523. PubMed ID: 33261565
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men.
Ryu S; Chang Y; Woo HY; Yoo SH; Choi NK; Lee WY; Kim I; Song J
Metabolism; 2010 May; 59(5):683-9. PubMed ID: 19922966
[TBL] [Abstract][Full Text] [Related]
18. Association of serum gamma-glutamyltransferase with chronic kidney disease risk: a meta-analysis.
Fan Y; Jin X; Man C; Gong D
Free Radic Res; 2018 Aug; 52(8):819-825. PubMed ID: 30208797
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.
Huang H; Wang XP; Li XH; Chen H; Zheng X; Lin JH; Kang T; Zhang L; Chen PS
BMC Cancer; 2017 Aug; 17(1):544. PubMed ID: 28806937
[TBL] [Abstract][Full Text] [Related]
20. Relationship between serum gamma-glutamyltransferase levels and prehypertension in Chinese adults: the cardiometabolic risk in Chinese study.
Zhu Y; Gong Y; Zhu R; Liu XK; Sun YT; Wang Y; Qi L; Liang J
J Clin Hypertens (Greenwich); 2014 Oct; 16(10):760-5. PubMed ID: 25113653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
